Abbott Laboratories Price to Free Cash Flow Ratio 2010-2023 | ABT
Historical price to free cash flow ratio values for Abbott Laboratories (ABT) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Abbott Laboratories Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2024-04-26 | 107.53 | 37.18 | |
| 2023-12-31 | 108.99 | $2.89 | 37.68 |
| 2023-09-30 | 95.36 | $2.56 | 37.25 |
| 2023-06-30 | 106.84 | $3.12 | 34.25 |
| 2023-03-31 | 98.75 | $3.88 | 25.47 |
| 2022-12-31 | 106.58 | $4.42 | 24.09 |
| 2022-09-30 | 93.50 | $4.82 | 19.39 |
| 2022-06-30 | 104.52 | $4.77 | 21.93 |
| 2022-03-31 | 113.42 | $4.57 | 24.84 |
| 2021-12-31 | 134.38 | $4.83 | 27.80 |
| 2021-09-30 | 112.36 | $5.21 | 21.56 |
| 2021-06-30 | 109.85 | $4.83 | 22.74 |
| 2021-03-31 | 113.13 | $4.26 | 26.58 |
| 2020-12-31 | 102.94 | $3.20 | 32.12 |
| 2020-09-30 | 101.98 | $2.57 | 39.64 |
| 2020-06-30 | 85.35 | $2.56 | 33.32 |
| 2020-03-31 | 73.37 | $2.51 | 29.20 |
| 2019-12-31 | 80.42 | $2.53 | 31.84 |
| 2019-09-30 | 77.16 | $2.15 | 35.96 |
| 2019-06-30 | 77.26 | $2.31 | 33.45 |
| 2019-03-31 | 73.14 | $2.51 | 29.11 |
| 2018-12-31 | 65.87 | $2.77 | 23.76 |
| 2018-09-30 | 66.53 | $2.78 | 23.91 |
| 2018-06-30 | 55.07 | $2.74 | 20.08 |
| 2018-03-31 | 53.85 | $2.83 | 19.00 |
| 2017-12-31 | 51.04 | $2.54 | 20.13 |
| 2017-09-30 | 47.50 | $2.36 | 20.12 |
| 2017-06-30 | 43.03 | $1.98 | 21.70 |
| 2017-03-31 | 39.08 | $1.80 | 21.66 |
| 2016-12-31 | 33.58 | $1.40 | 23.92 |
| 2016-09-30 | 36.74 | $1.22 | 30.15 |
| 2016-06-30 | 33.94 | $1.13 | 30.16 |
| 2016-03-31 | 35.90 | $1.16 | 30.96 |
| 2015-12-31 | 38.30 | $1.23 | 31.08 |
| 2015-09-30 | 34.10 | $1.47 | 23.27 |
| 2015-06-30 | 41.41 | $1.55 | 26.68 |
| 2015-03-31 | 38.89 | $1.50 | 26.01 |
| 2014-12-31 | 37.59 | $1.70 | 22.09 |
| 2014-09-30 | 34.54 | $1.92 | 17.98 |
| 2014-06-30 | 33.79 | $1.47 | 22.94 |
| 2014-03-31 | 31.62 | $1.32 | 23.97 |
| 2013-12-31 | 31.30 | $1.38 | 22.61 |
| 2013-09-30 | 26.99 | $1.25 | 21.52 |
| 2013-06-30 | 28.25 | $2.96 | 9.54 |
| 2013-03-31 | 28.50 | $3.73 | 7.65 |
| 2012-12-31 | 25.29 | $4.72 | 5.36 |
| 2012-09-30 | 26.38 | $4.71 | 5.60 |
| 2012-06-30 | 24.71 | $4.50 | 5.50 |
| 2012-03-31 | 23.40 | $4.82 | 4.86 |
| 2011-12-31 | 21.38 | $4.74 | 4.51 |
| 2011-09-30 | 19.36 | $5.35 | 3.62 |
| 2011-06-30 | 19.83 | $5.20 | 3.82 |
| 2011-03-31 | 18.40 | $5.18 | 3.55 |
| 2010-12-31 | 17.90 | $4.96 | 3.61 |
| 2010-09-30 | 19.44 | $4.68 | 4.15 |
| 2010-06-30 | 17.33 | $4.91 | 3.53 |
| 2010-03-31 | 19.43 | $4.51 | 4.31 |
| 2009-12-31 | 19.85 | $3.98 | 4.99 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $186.584B | $40.109B |
| Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stryker (SYK) | United States | $127.689B | 31.66 |
| Boston Scientific (BSX) | United States | $107.347B | 34.19 |
| Medtronic (MDT) | Ireland | $105.881B | 14.99 |
| EssilorLuxottica (ESLOY) | France | $98.567B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.036B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.584B | 30.18 |
| ResMed (RMD) | United States | $32.074B | 30.08 |
| Terumo (TRUMY) | Japan | $24.746B | 34.95 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.522B | 15.79 |
| Baxter (BAX) | United States | $20.379B | 14.86 |
| Koninklijke Philips (PHG) | Netherlands | $19.567B | 15.61 |
| Insulet (PODD) | United States | $11.637B | 61.10 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.689B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.869B | 23.44 |
| BellRing Brands (BRBR) | United States | $7.379B | 39.68 |
| Haemonetics (HAE) | United States | $4.621B | 23.63 |
| Lantheus Holdings (LNTH) | United States | $4.494B | 11.60 |
| Perrigo (PRGO) | Ireland | $4.328B | 12.38 |
| GN Store Nord (GNNDY) | Denmark | $4.065B | 26.32 |
| Envista Holdings (NVST) | United States | $3.504B | 13.33 |
| Prestige Consumer Healthcare (PBH) | United States | $3.499B | 16.54 |
| QuidelOrtho (QDEL) | United States | $2.651B | 9.62 |
| Neogen (NEOG) | United States | $2.630B | 25.29 |
| Green Thumb Industries (GTBIF) | United States | $2.571B | 81.47 |
| ICU Medical (ICUI) | United States | $2.311B | 17.24 |
| TG Therapeutics (TGTX) | United States | $2.082B | 673.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.936B | 0.00 |
| Owens & Minor (OMI) | United States | $1.922B | 18.45 |
| Agios Pharmaceuticals (AGIO) | United States | $1.770B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.697B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.469B | 48.49 |
| InMode (INMD) | Israel | $1.439B | 7.45 |
| National Vision Holdings (EYE) | United States | $1.400B | 43.61 |
| AdaptHealth (AHCO) | United States | $1.324B | 9.96 |
| Warby Parker (WRBY) | United States | $1.280B | 0.00 |
| AtriCure (ATRC) | United States | $1.121B | 0.00 |
| MacroGenics (MGNX) | United States | $0.911B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.893B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.794B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.682B | 14.73 |
| Evolus (EOLS) | United States | $0.662B | 0.00 |
| Jin Medical (ZJYL) | China | $0.626B | 0.00 |
| Quanterix (QTRX) | United States | $0.595B | 0.00 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.516B | 11.17 |
| PetIQ (PETQ) | United States | $0.487B | 18.17 |
| TerrAscend (TSNDF) | Canada | $0.486B | 0.00 |
| ZimVie (ZIMV) | United States | $0.431B | 26.37 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.407B | 6.73 |
| Surmodics (SRDX) | United States | $0.373B | 40.26 |
| Aurora Cannabis (ACB) | Canada | $0.365B | 0.00 |
| Zynex (ZYXI) | United States | $0.361B | 41.52 |
| Viemed Healthcare (VMD) | United States | $0.322B | 31.96 |
| Cerus (CERS) | United States | $0.310B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.279B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.250B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.237B | 14.65 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| Veru (VERU) | United States | $0.186B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
| Omeros (OMER) | United States | $0.183B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
| High Tide (HITI) | Canada | $0.161B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.144B | 72.36 |
| FitLife Brands (FTLF) | United States | $0.132B | 21.28 |
| Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
| InterCure (INCR) | Israel | $0.121B | 20.46 |
| Fonar (FONR) | United States | $0.103B | 8.84 |
| MariMed (MRMD) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
| Safety Shot (SHOT) | United States | $0.082B | 0.00 |
| Chimerix (CMRX) | United States | $0.080B | 0.00 |
| Brainsway (BWAY) | Israel | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.058B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.054B | 3.53 |
| Apyx Medical (APYX) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.77 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |